Spanish biotech OneChain Immunotherapeutics (OCI), has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA)to OC-1, a CAR T therapy against for the treatment of acute lymp...
Read moreLa empresa, dirigida por el doctor Pablo Escribá, ha desarrollado Lam561, un fármaco específico para combatir el glioblastoma y prolongar la esperanza de vida de los pacientes afectados por este ti...
Read moreInvestigadores del Hospital del Mar Research Institute han descrito, por primera vez, un marcador que puede ayudar a predecir qué pacientes con Alzheimer u otro tipo de demencias sufrirán una evoluc...
Read moreEl equipo científico de la Universidad Pablo de Olavide dirigido por el catedrático José Antonio Sánchez Alcázar ha publicado recientemente un estudio en la revista International Journal of Molec...
Read moreThey show that anti-MOG antibodies are rare in adults presenting with a first demyelinating flare suggestive of multiple sclerosis. However, they recommend determining their presence in those patients...
Read moreThis project aims to understand fundamental aspects of oocyte development which might help address unexplained infertility, which accounts for around one in four cases of infertility
Read moreEl hallazgo de efectos genotóxicos tras la utilización de editores de bases y editores de calidad para la modificación del genoma en células madre hematopoyéticas plantea la necesidad de evaluar ...
Read moreInvestigadores de la Universidad de Santiago de Compostela han secuenciado por primera vez los genomas de cánceres transmisibles de berberechos, lo que revela un genoma desestructurado que no se obse...
Read moreOne of the highlights of his presentation was the estimate that the Mediterranean per diem expenses could lose between 12% and 24% of its protection if moderate wine consumption, defined as up to 1 gl...
Read moreBreast milk levels of cytokines, key molecules for the newborn's immune system, can be affected by the mother's diet and premature birth. This is evidenced by new research from the Autonomous Universi...
Read moreADmit Therapeutics is a biotechnology company founded at the end of 2017 as a spin-off from the Bellvitge Biomedical Research Institute (IDIBELL). The company is focused on the development and commerc...
Read moreThe study emphasizes the role of neuron-derived extracellular vesicles in the processes that modulate synaptic plasticity and neuronal signalling pathways. In addition, the results outline a new scena...
Read more